Business
AstraZeneca unveils antibody treatment, preventative shot for those who can’t get vaccinated – The Sydney Morning Herald
The company said its drug offered hope to those who can’t receive COVID-19 vaccines, such as cancer patients, organ transplant…
The full results will be submitted for publication in a peer-reviewed medical journal.
Pascal Soriot, CEO of AstraZeneca, said the data showed the drug offered protection for six months and could last for 12 months, but the company needed a further six…
Continue Reading
-
General16 hours agoWest Indies vs Australia live: Second Test, day two from Grenada
-
General21 hours agoFederal government commits $430 million to prop up Newcastle hydrogen hub
-
Noosa News20 hours agoHow the AG’s constant appeals could change sentencing trends
-
Noosa News18 hours agoRailed! at Wynnum Fringe: All the Details